Literature DB >> 22864622

Aurora A kinase (AURKA) in normal and pathological cell division.

Anna S Nikonova1, Igor Astsaturov, Ilya G Serebriiskii, Roland L Dunbrack, Erica A Golemis.   

Abstract

Temporally and spatially controlled activation of the Aurora A kinase (AURKA) regulates centrosome maturation, entry into mitosis, formation and function of the bipolar spindle, and cytokinesis. Genetic amplification and mRNA and protein overexpression of Aurora A are common in many types of solid tumor, and associated with aneuploidy, supernumerary centrosomes, defective mitotic spindles, and resistance to apoptosis. These properties have led Aurora A to be considered a high-value target for development of cancer therapeutics, with multiple agents currently in early-phase clinical trials. More recently, identification of additional, non-mitotic functions and means of activation of Aurora A during interphase neurite elongation and ciliary resorption have significantly expanded our understanding of its function, and may offer insights into the clinical performance of Aurora A inhibitors. Here we review the mitotic and non-mitotic functions of Aurora A, discuss Aurora A regulation in the context of protein structural information, and evaluate progress in understanding and inhibiting Aurora A in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864622      PMCID: PMC3607959          DOI: 10.1007/s00018-012-1073-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  228 in total

1.  CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function.

Authors:  Naoko Kunitoku; Takashi Sasayama; Tomotoshi Marumoto; Dongwei Zhang; Shinobu Honda; Osamu Kobayashi; Katsuyoshi Hatakeyama; Yukitaka Ushio; Hideyuki Saya; Toru Hirota
Journal:  Dev Cell       Date:  2003-12       Impact factor: 12.270

2.  Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.

Authors:  Gong Yang; Bin Chang; Fan Yang; Xiaoqing Guo; Kathy Qi Cai; Xue Sherry Xiao; Huamin Wang; Subrata Sen; Mien-Chie Hung; Gordon B Mills; Sandy Chang; Asha S Multani; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-04-27       Impact factor: 12.531

3.  Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

Authors:  Arijit Chakravarty; Vaishali Shinde; Josep Tabernero; Andres Cervantes; Roger B Cohen; E Claire Dees; Howard Burris; Jeffrey R Infante; Teresa Macarulla; Elena Elez; Jordi Andreu; Edith Rodriguez-Braun; Susana Rosello; Margaret von Mehren; Neal J Meropol; Corey J Langer; Bert ONeil; Douglas Bowman; Mengkun Zhang; Hadi Danaee; Laura Faron-Yowe; Gary Gray; Hua Liu; Jodi Pappas; Lee Silverman; Chris Simpson; Bradley Stringer; Stephen Tirrell; Ole Petter Veiby; Karthik Venkatakrishnan; Katherine Galvin; Mark Manfredi; Jeffrey A Ecsedy
Journal:  Cancer Res       Date:  2010-12-10       Impact factor: 12.701

4.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.

Authors:  Jian-Hua Mao; Jesus Perez-Losada; Di Wu; Reyno Delrosario; Ryosuke Tsunematsu; Keiichi I Nakayama; Ken Brown; Sheila Bryson; Allan Balmain
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

Review 5.  Human cancers express mutator phenotypes: origin, consequences and targeting.

Authors:  Lawrence A Loeb
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

6.  Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.

Authors:  Jian-Hua Mao; Di Wu; Jesus Perez-Losada; Tao Jiang; Qian Li; Richard M Neve; Joe W Gray; Wei-Wen Cai; Allan Balmain
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

7.  Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.

Authors:  Alfred King-Yin Lam; Kate Ong; Yik-Hong Ho
Journal:  Hum Pathol       Date:  2008-03-04       Impact factor: 3.466

Review 8.  HEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networks.

Authors:  Elena N Pugacheva; Erica A Golemis
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

9.  Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans.

Authors:  E Hannak; M Kirkham; A A Hyman; K Oegema
Journal:  J Cell Biol       Date:  2001-12-17       Impact factor: 10.539

10.  Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC).

Authors:  Eiji Ogawa; Kazumasa Takenaka; Hiromichi Katakura; Masashi Adachi; Yosuke Otake; Yoshinobu Toda; Hirokazu Kotani; Toshiaki Manabe; Hiromi Wada; Fumihiro Tanaka
Journal:  Ann Surg Oncol       Date:  2007-11-28       Impact factor: 5.344

View more
  181 in total

1.  INPP5E interacts with AURKA, linking phosphoinositide signaling to primary cilium stability.

Authors:  Olga V Plotnikova; Seongjin Seo; Denny L Cottle; Sarah Conduit; Sandra Hakim; Jennifer M Dyson; Christina A Mitchell; Ian M Smyth
Journal:  J Cell Sci       Date:  2014-11-13       Impact factor: 5.285

2.  The tumor suppressor FBW7 controls ciliary length.

Authors:  Anna S Nikonova; Erica A Golemis
Journal:  EMBO J       Date:  2015-08-12       Impact factor: 11.598

Review 3.  Ubiquitin, the centrosome, and chromosome segregation.

Authors:  Ying Zhang; Paul J Galardy
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

4.  Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells.

Authors:  Chad N Brocker; Jiang Yue; Donghwan Kim; Aijuan Qu; Jessica A Bonzo; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-12       Impact factor: 4.052

Review 5.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

Review 6.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 7.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

Review 8.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

9.  Aurora kinase A localises to mitochondria to control organelle dynamics and energy production.

Authors:  Giulia Bertolin; Anne-Laure Bulteau; Marie-Clotilde Alves-Guerra; Agnes Burel; Marie-Thérèse Lavault; Olivia Gavard; Stephanie Le Bras; Jean-Philippe Gagné; Guy G Poirier; Roland Le Borgne; Claude Prigent; Marc Tramier
Journal:  Elife       Date:  2018-08-02       Impact factor: 8.140

10.  The structure of C290A:C393A Aurora A provides structural insights into kinase regulation.

Authors:  Selena G Burgess; Richard Bayliss
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-02-19       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.